Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 21640651)

1.

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N.

Lancet Neurol. 2011 Jul;10(7):618-25. doi: 10.1016/S1474-4422(11)70108-9. Epub 2011 Jun 2.

PMID:
21640651
2.

Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.

Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY.

J Neurosurg. 2013 Jul;119(1):180-9. doi: 10.3171/2013.3.JNS121436. Epub 2013 May 3. Review.

PMID:
23641823
3.

Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study.

Pearl JD, Macdonald RL.

Acta Neurochir Suppl. 2008;105:207-10. Review.

PMID:
19066110
4.

Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.

Vergouwen MD, Algra A, Rinkel GJ.

Stroke. 2012 Oct;43(10):2671-6. Epub 2012 Aug 7. Review. Erratum in: Stroke. 2013 Jun;44(6):e72.

5.

Endothelin receptor antagonists for subarachnoid hemorrhage.

Guo J, Shi Z, Yang K, Tian JH, Jiang L.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD008354. doi: 10.1002/14651858.CD008354.pub2. Review.

PMID:
22972119
6.

[Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 2].

Verger Bennasar AM, Romero Kräuchi O.

Rev Esp Anestesiol Reanim. 2011 Apr;58(4):236-42. Review. Spanish. No abstract available.

PMID:
21608280
7.

SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Macdonald RL, Jaja B, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, Lantigua H, Le Roux P, Lo B, Louffat-Olivares A, Mayer S, Molyneux A, Quinn A, Schweizer TA, Schenk T, Spears J, Todd M, Torner J, Vergouwen MD, Wong GK, Singh J; SAHIT Collaboration.

Transl Stroke Res. 2013 Jun;4(3):286-96. doi: 10.1007/s12975-012-0242-1. Epub 2013 Jan 7. Review.

PMID:
24323299
8.

From bench-to-bedside in catastrophic cerebrovascular disease: development of drugs targeting the endothelin axis in subarachnoid hemorrhage-related vasospasm.

Ardelt A.

Neurol Res. 2012 Mar;34(2):195-210. doi: 10.1179/1743132811Y.0000000081. Epub 2012 Feb 2. Review.

PMID:
22333896
9.

Novel treatments for vasospasm after subarachnoid hemorrhage.

Muroi C, Seule M, Mishima K, Keller E.

Curr Opin Crit Care. 2012 Apr;18(2):119-26. doi: 10.1097/MCC.0b013e32835075ae. Review.

PMID:
22234053
10.

Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study.

McGirt MJ, Garces Ambrossi GL, Huang J, Tamargo RJ.

J Neurosurg. 2009 May;110(5):968-74. doi: 10.3171/2008.10.JNS08901. Review.

PMID:
19199459
11.

Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

de Oliveira JG, Beck J, Ulrich C, Rathert J, Raabe A, Seifert V.

Neurosurg Rev. 2007 Jan;30(1):22-30; discussion 30-1. Epub 2006 Oct 24. Review.

PMID:
17061137
12.

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.

Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB.

Stroke. 2010 Jan;41(1):e47-52. doi: 10.1161/STROKEAHA.109.556332. Epub 2009 Oct 29. Review.

13.

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution.

Macdonald RL, Pluta RM, Zhang JH.

Nat Clin Pract Neurol. 2007 May;3(5):256-63. Review.

PMID:
17479073
14.

Intravenous magnesium therapy in adult patients with an aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.

Yarad EA, Hammond NE.

Aust Crit Care. 2013 Aug;26(3):105-17. doi: 10.1016/j.aucc.2013.05.002. Epub 2013 Jun 24. Review.

PMID:
23806874
15.

To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.

Cossu G, Messerer M, Oddo M, Daniel RT.

Biomed Res Int. 2014;2014:628597. doi: 10.1155/2014/628597. Epub 2014 May 19. Review.

16.

Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage.

Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N.

Lancet Neurol. 2003 Oct;2(10):614-21. Review.

PMID:
14505583
17.

Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage.

Shimamura N, Ohkuma H.

Transl Stroke Res. 2014 Jun;5(3):357-64. doi: 10.1007/s12975-013-0310-1. Epub 2013 Nov 20. Review.

PMID:
24323729
18.

Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought.

Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, Kasuya H, Wellman G, Keller E, Zauner A, Dorsch N, Clark J, Ono S, Kiris T, Leroux P, Zhang JH.

Neurol Res. 2009 Mar;31(2):151-8. doi: 10.1179/174313209X393564. Review.

19.
20.

Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.

Przybycien-Szymanska MM, Ashley WW Jr.

J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1453-64. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.047. Epub 2015 May 6. Review.

PMID:
25957908
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk